Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes
To access this article, please choose from the options below
This research was sponsored by the Canadian Heart Research Centre and Key Pharmaceuticals, Division of Schering Canada Inc. Drs Fitchett, Lauzon, Lai, Langer, and Goodman have received research grant support and speaker/consultant honoraria from Schering Canada Inc. Dr McGuire has received research grant support and speaker/consultant honoraria from Pfizer, GlaxoSmithKline, Wyeth, Sanofi-Aventis, Guilford, and Takeda. Dr Andrew Yan is supported by the Canadian Institutes of Health Research Fellowship Award, the Canadian Heart Research Centre Fellowship, and the Detweiler Travelling Fellowship.
PII: S0002-8703(06)00322-X
doi:10.1016/j.ahj.2006.04.002
© 2006 Mosby, Inc. All rights reserved.
